vs
Side-by-side financial comparison of OP Bancorp (OPBK) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $24.3M, roughly 1.6× OP Bancorp). On growth, OP Bancorp posted the faster year-over-year revenue change (13.7% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $23.4M). Over the past eight quarters, OP Bancorp's revenue compounded faster (11.4% CAGR vs -15.0%).
OP Bancorp is the bank holding company for Open Bank, a community-oriented commercial bank headquartered in California, United States. It provides a full range of banking solutions including deposit accounts, commercial real estate loans, small business financing, and consumer lending products, primarily catering to small and medium-sized enterprises, local immigrant communities, and retail clients across Southern California.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
OPBK vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.3M | $39.6M |
| Net Profit | — | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 39.2% | 32.5% |
| Net Margin | — | 35.9% |
| Revenue YoY | 13.7% | -10.9% |
| Net Profit YoY | — | 117.2% |
| EPS (diluted) | $0.48 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.3M | $39.6M | ||
| Q3 25 | $24.5M | $43.4M | ||
| Q2 25 | $23.7M | $43.4M | ||
| Q1 25 | $22.2M | $47.3M | ||
| Q4 24 | $21.3M | $44.4M | ||
| Q3 24 | $20.7M | $53.1M | ||
| Q2 24 | $20.4M | $53.1M | ||
| Q1 24 | $19.6M | $54.8M |
| Q4 25 | — | $14.2M | ||
| Q3 25 | $6.7M | $12.8M | ||
| Q2 25 | $6.3M | $2.5M | ||
| Q1 25 | $5.6M | $21.5M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | $5.4M | $2.8M | ||
| Q2 24 | $5.4M | $18.5M | ||
| Q1 24 | $5.2M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 39.2% | 32.5% | ||
| Q3 25 | 39.5% | 36.6% | ||
| Q2 25 | 35.7% | 33.6% | ||
| Q1 25 | 34.6% | 51.1% | ||
| Q4 24 | 31.2% | 10.6% | ||
| Q3 24 | 36.5% | 26.1% | ||
| Q2 24 | 37.2% | 51.4% | ||
| Q1 24 | 37.1% | 44.6% |
| Q4 25 | — | 35.9% | ||
| Q3 25 | 27.4% | 29.6% | ||
| Q2 25 | 26.7% | 5.7% | ||
| Q1 25 | 25.0% | 45.4% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | 26.2% | 5.3% | ||
| Q2 24 | 26.7% | 34.8% | ||
| Q1 24 | 26.7% | 34.2% |
| Q4 25 | $0.48 | $0.15 | ||
| Q3 25 | $0.45 | $0.12 | ||
| Q2 25 | $0.42 | $0.02 | ||
| Q1 25 | $0.37 | $0.21 | ||
| Q4 24 | $0.33 | $0.05 | ||
| Q3 24 | $0.36 | $0.03 | ||
| Q2 24 | $0.36 | $0.20 | ||
| Q1 24 | $0.34 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $227.9M | $248.3M |
| Total Assets | $2.7B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $164.1M | ||
| Q3 25 | $166.7M | $127.4M | ||
| Q2 25 | $205.4M | $152.7M | ||
| Q1 25 | $198.9M | $132.1M | ||
| Q4 24 | $134.9M | $125.0M | ||
| Q3 24 | $166.8M | $137.4M | ||
| Q2 24 | $127.7M | — | ||
| Q1 24 | $139.2M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $227.9M | $248.3M | ||
| Q3 25 | $221.5M | $248.0M | ||
| Q2 25 | $213.7M | $244.6M | ||
| Q1 25 | $210.1M | $226.4M | ||
| Q4 24 | $205.0M | $195.1M | ||
| Q3 24 | $203.6M | $205.0M | ||
| Q2 24 | $195.9M | $8.8M | ||
| Q1 24 | $194.7M | $9.0M |
| Q4 25 | $2.7B | $380.4M | ||
| Q3 25 | $2.6B | $321.4M | ||
| Q2 25 | $2.6B | $315.3M | ||
| Q1 25 | $2.5B | $284.6M | ||
| Q4 24 | $2.4B | $266.1M | ||
| Q3 24 | $2.4B | $296.5M | ||
| Q2 24 | $2.3B | $19.5M | ||
| Q1 24 | $2.2B | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $52.0M |
| Free Cash FlowOCF − Capex | $23.4M | $51.2M |
| FCF MarginFCF / Revenue | 96.2% | 129.3% |
| Capex IntensityCapex / Revenue | 11.5% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $43.3M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $52.0M | ||
| Q3 25 | $23.9M | $-20.9M | ||
| Q2 25 | $-7.0M | $-8.3M | ||
| Q1 25 | $5.6M | $1.9M | ||
| Q4 24 | $31.2M | $-7.3M | ||
| Q3 24 | $13.3M | $5.0M | ||
| Q2 24 | $15.8M | $19.2M | ||
| Q1 24 | $-3.2M | $3.7M |
| Q4 25 | $23.4M | $51.2M | ||
| Q3 25 | $23.4M | $-20.9M | ||
| Q2 25 | $-7.7M | $-8.6M | ||
| Q1 25 | $4.2M | $1.7M | ||
| Q4 24 | $29.7M | $-7.9M | ||
| Q3 24 | $12.8M | $4.6M | ||
| Q2 24 | $15.7M | $18.3M | ||
| Q1 24 | $-3.2M | $3.0M |
| Q4 25 | 96.2% | 129.3% | ||
| Q3 25 | 95.6% | -48.3% | ||
| Q2 25 | -32.5% | -19.9% | ||
| Q1 25 | 19.0% | 3.5% | ||
| Q4 24 | 139.0% | -17.8% | ||
| Q3 24 | 61.5% | 8.7% | ||
| Q2 24 | 77.0% | 34.5% | ||
| Q1 24 | -16.6% | 5.4% |
| Q4 25 | 11.5% | 2.0% | ||
| Q3 25 | 2.3% | 0.1% | ||
| Q2 25 | 3.0% | 0.7% | ||
| Q1 25 | 6.4% | 0.5% | ||
| Q4 24 | 7.3% | 1.3% | ||
| Q3 24 | 2.8% | 0.8% | ||
| Q2 24 | 0.4% | 1.6% | ||
| Q1 24 | 0.5% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | 3.57× | -1.63× | ||
| Q2 25 | -1.10× | -3.39× | ||
| Q1 25 | 1.02× | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 2.45× | 1.77× | ||
| Q2 24 | 2.90× | 1.04× | ||
| Q1 24 | -0.60× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPBK
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
